CVE-2020-10627 HIGH

CVE-2020-10627

Vendor Insulet
Product Omnipod Insulin Management System
Weakness CWE-284
Published December 1, 2021
Last update August 4, 2024

CVSS base score

7.3/10
Attack vector Local
Attack complexity Low
Privileges required None
User interaction None
Confidentiality Low
Integrity High

CVSS vector

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L

What the vulnerability does

01Description

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Key dates

02Disclosure timeline

December 1, 2021 CVE published
August 4, 2024 Record updated